Royal Bank of Canada’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13K Buy
1,413
+118
+9% +$990 ﹤0.01% 6054
2025
Q4
$10K Buy
1,295
+709
+121% +$5.1K ﹤0.01% 6403
2025
Q3
$4K Buy
586
+454
+344% +$3.15K ﹤0.01% 6736
2025
Q2
$1K Sell
132
-864
-87% -$6.13K ﹤0.01% 6857
2025
Q1
$9K Sell
996
-2,564
-72% -$25.6K ﹤0.01% 6183
2024
Q4
$37K Sell
3,560
-603
-14% -$7.13K ﹤0.01% 5835
2024
Q3
$50K Buy
4,163
+632
+18% +$5.46K ﹤0.01% 5698
2024
Q2
$20K Buy
3,531
+3,345
+1,798% +$18.3K ﹤0.01% 6069
2024
Q1
$1K Sell
186
-3,940
-95% -$19.3K ﹤0.01% 6764
2023
Q4
$22K Buy
+4,126
New +$16.3K ﹤0.01% 6266
2023
Q2
Sell
-2,416
Closed -$3K 7270
2023
Q1
$3K Sell
2,416
-8,860
-79% -$16.9K ﹤0.01% 6676
2022
Q4
$28K Buy
11,276
+6,398
+131% +$27.9K ﹤0.01% 6156
2022
Q3
$35K Buy
4,878
+327
+7% +$2.56K ﹤0.01% 5911
2022
Q2
$32K Sell
4,551
-1,634
-26% -$16.7K ﹤0.01% 5908
2022
Q1
$87K Sell
6,185
-3,992
-39% -$53.4K ﹤0.01% 5751
2021
Q4
$147K Buy
10,177
+5,132
+102% +$73K ﹤0.01% 5648
2021
Q3
$71K Buy
5,045
+2,470
+96% +$38K ﹤0.01% 5945
2021
Q2
$45K Sell
2,575
-234
-8% -$3.77K ﹤0.01% 6108
2021
Q1
$43K Buy
+2,809
New +$40K ﹤0.01% 5984

Other funds holding BVS

Royal Bank of Canada's BVS Position: Q1 2026 in Review

Royal Bank of Canada increased its Bioventus (BVS) stake by 9.1% in Q1 2026, buying an estimated $990 and bringing the position to 1,413 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #6054.

Royal Bank of Canada first reported a position in BVS in Q1 2021 and has held it in 19 quarters since. The position peaked at $147K in Q4 2021. 157 funds tracked by Wall St. Rank hold BVS as of Q1 2026.

  • Royal Bank of Canada held 1,413 shares of Bioventus worth $13K as of Q1 2026.
  • Royal Bank of Canada bought 118 Bioventus shares in Q1 2026, an estimated $990.
  • Bioventus made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6054 holding.
  • Royal Bank of Canada first reported a position in Bioventus in Q1 2021 and has held it in 19 quarters since.
  • Royal Bank of Canada's Bioventus position peaked at $147K in Q4 2021.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.